Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 Apr 29;63(5):588–644. [Article in German] doi: 10.1007/s00103-020-03123-w

Impfen bei Immundefizienz

Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (III) Impfen bei hämatologischen und onkologischen Erkrankungen (antineoplastische Therapie, Stammzelltransplantation), Organtransplantation und Asplenie

Hans-Jürgen Laws 1, Ulrich Baumann 2, Christian Bogdan 3,4, Gerd Burchard 4,5, Maximilian Christopeit 6, Jane Hecht 7, Ulrich Heininger 4,8, Inken Hilgendorf 9, Winfried Kern 10, Kerstin Kling 11,✉, Guido Kobbe 12, Wiebe Külper 11, Thomas Lehrnbecher 13, Roland Meisel 1, Arne Simon 14, Andrew Ullmann 15, Maike de Wit 16,17, Fred Zepp 4,18
PMCID: PMC7223132  PMID: 32350583

The content is available as a PDF (3.9 MB).

Acknowledgments

Danksagung

Für die kritische und konstruktive Durchsicht des Manuskripts danken wir allen in der STIKO-Arbeitsgruppe Immundefizienz mitarbeitenden Expertinnen und Experten sowie Miriam Wiese-Posselt, Judith Koch und Sabine Vygen-Bonnet, für die redaktionelle Durchsicht Eva Wetzel aus dem Fachgebiet Impfprävention am Robert Koch Institut. Ein besonderer Dank gilt auch Christof Schaefer vom Pharmakovigilanzzentrum Embryonaltoxikologie der Charité-Universitätsmedizin Berlin für die kritische Begutachtung und fachlicher Beratung im Abschnitt in utero-Exposition.

Abkürzungen

AI

Auffrischimpfung

AK

Antikörper

ALL

Akute Lymphatische Leukämie

Anti-HBs

Antikörper gegen Hepatitis B-surface-Antigen

ASCO

American Society of Clinical Oncology

CD

Cluster of Differentiation

CI

Checkpoint-Inhibitoren

CLL

Chronisch Lymphatische Leukämie

CMV

Cytomegalievirus

cVDPV

circulating Vaccine-Derived Poliovirus

EBMT

engl. European Society for Blood and Marrow-Transplantion, Europäische Gesellschaft für Blut- und Knochenmarkstransplantation

EK

Erythrozytenkonzentrat

ELISA

Enzyme-Linked Immuno Sorbent Assay

ESMO

European Society for Medical Oncology

FFP

Fresh Frozen Plasma

FSME

Frühsommermeningoenzephalitis

GI

Grundimmunisierung

GKV

Gesetzliche Krankenversicherung

GvHD

Graft-versus-Host-Disease

Hep B

Hepatitis B

HBsAg

Hepatitis B-surface-Antigen

Hib

Haemophilus influenza Typ b

HIV

Humanes Immundefizienz-Virus

HPV

Humanes Papillomavirus

Hz

Herpes zoster

IDWP

Infectious Disease Working Party der EBMT

Ig

Immunglobuline

IgG

Immunglobulin G

IPD

engl. Invasive Pneumococcal Diseases, invasive Pneumokokkenerkrankungen

IME

Invasive Meningokokkenerkrankungen

IPV

Inaktivierte Poliomyelitisvakzine

IVIg

Intravenöse Immunglobuline

JE

Japanische Enzephalitis

LAIV

engl. Live-Attenuated Influenza Vaccine, attenuierter Lebendinfluenzaimpfstoff

MMR

Masern, Mumps, Röteln

MenC

Meningokokken C

mTOR

mechanistic (früher mammalian) Target Of Rapamycin

NT

Neutralisationstest

OPSI

Overwhelming Post-Splenectomy Infection Syndrome

PCV13

13-valenter Pneumokokken-Konjugatimpfstoff

PEP

Postexpositions-Prophylaxe

PPSV23

23-valenter Pneumokokken-Polysaccharid-Impfstoff

PRNT

Plaque Reduction Neutralization Test

RFFIT

Rapid Fluorescent Focus Inhibition Test

rSBA

rabbit Serum Bactericidal Assay

STIKO

Ständige Impfkommission

SZT

Stammzelltransplantation

TK

Thrombozytenkonzentrat

TKI

Tyrosinkinaseinhibitoren

TNF

Tumornekrosefaktor

Tx

Transplantation

UAW

unerwünschte Arzneimittelwirkungen

VZV

Varicella-Zoster-Virus

WHO

engl. World Health Organisation, Weltgesundheitsorganisation

WPV

Wildpoliomyelitisvirus

Interessenkonflikt

H.-J. Laws, U. Baumann, C. Bogdan, G. Burchard, M. Christopeit, J. Hecht, U. Heininger, I. Hilgendorf, W. Kern, K. Kling, G. Kobbe, W. Külper, T. Lehrnbecher, R. Meisel, A. Simon, A. Ullmann, M. de Wit und F. Zepp geben an, dass kein Interessenkonflikt besteht.

Literatur

  • 1.Acar S, Gencdal G, Kirimlioglu H, Polat KY, Cagatay AA, Akyildiz M. Varicella-Zoster Virus-Induced Hepatitis in a Liver Transplant Recipient: A Case Report. Transplant Proc. 2019;51:1193–1195. doi: 10.1016/j.transproceed.2019.01.092. [DOI] [PubMed] [Google Scholar]
  • 2.Agency EM (2018) Summary of product characteristics—Shingrix. https://www.ema.europa.eu/en/documents/product-information/shingrix-epar-product-information_en.pdf. Zugegriffen: 18. März 2020
  • 3.Ambati A, Einarsdottir S, Magalhaes I, et al. Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients. Transpl Infect Dis. 2015;17:371–379. doi: 10.1111/tid.12382. [DOI] [PubMed] [Google Scholar]
  • 4.Ammann AJ, Addiego J, Wara DW, et al. Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy. N Engl J Med. 1977;297:897–900. doi: 10.1056/NEJM197710272971701. [DOI] [PubMed] [Google Scholar]
  • 5.Anderson EJ. Rotavirus vaccines: viral shedding and risk of transmission. Lancet Infect Dis. 2008;8:642–649. doi: 10.1016/S1473-3099(08)70231-7. [DOI] [PubMed] [Google Scholar]
  • 6.Anderson H, Petrie K, Berrisford C, et al. Seroconversion after influenza vaccination in patients with lung cancer. Br J Cancer. 1999;80:219–220. doi: 10.1038/sj.bjc.6690342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ando S. Effectiveness of quadrivalent influenza vaccine based on the test-negative control study in children during the 2016–2017 season. J Infect Chemother. 2018;24:782–788. doi: 10.1016/j.jiac.2018.05.012. [DOI] [PubMed] [Google Scholar]
  • 8.Antonelli NM, Dotters DJ, Katz VL, et al. Cancer in pregnancy: a review of the literature. Part I. Obstet Gynecol Surv. 1996;51:125–134. doi: 10.1097/00006254-199602000-00022. [DOI] [PubMed] [Google Scholar]
  • 9.Arnott A, Jones P, Franklin LJ, et al. A Registry for Patients With Asplenia/Hyposplenism Reduces the Risk of Infections With Encapsulated Organisms. Clin Infect Dis. 2018;67:557–561. doi: 10.1093/cid/ciy141. [DOI] [PubMed] [Google Scholar]
  • 10.Arslan M, Wiesner RH, Poterucha JJ, et al. Hepatitis A antibodies in liver transplant recipients: evidence for loss of immunity posttransplantation. Liver Transpl. 2000;6:191–195. doi: 10.1002/lt.500060216. [DOI] [PubMed] [Google Scholar]
  • 11.Arslan M, Wiesner RH, Poterucha JJ, et al. Safety and efficacy of hepatitis A vaccination in liver transplantation recipients. Transplantation. 2001;72:272–276. doi: 10.1097/00007890-200107270-00019. [DOI] [PubMed] [Google Scholar]
  • 12.Aung AK, Trubiano JA, Spelman DW. Travel risk assessment, advice and vaccinations in immunocompromised travellers (HIV, solid organ transplant and haematopoeitic stem cell transplant recipients): A review. Travel Med Infect Dis. 2015;13:31–47. doi: 10.1016/j.tmaid.2014.12.007. [DOI] [PubMed] [Google Scholar]
  • 13.Australian Technical Advisory Group on Immunisation (ATAGI) Australian Immunisation Handbook. In: Health AGDo, editor. Vaccination for special risk groups. Canberra: Australian Government Department of Health; 2018. [Google Scholar]
  • 14.Avelino-Silva VI, Freire Mda S, Rocha V, et al. Persistence of Yellow Fever vaccine-induced antibodies after cord blood stem cell transplant. Hum Vaccines Immunother. 2016;12:937–938. doi: 10.1080/21645515.2015.1112475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Avery RK. Influenza vaccines in the setting of solid-organ transplantation: are they safe? Curr Opin Infect Dis. 2012;25:464–468. doi: 10.1097/QCO.0b013e328355a79b. [DOI] [PubMed] [Google Scholar]
  • 16.Avery RK, Michaels M. Update on immunizations in solid organ transplant recipients: what clinicians need to know. Am J Transplant. 2008;8:9–14. doi: 10.1111/j.1600-6143.2007.02051.x. [DOI] [PubMed] [Google Scholar]
  • 17.Avetisyan G, Aschan J, Hassan M, et al. Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation. Transplantation. 2008;86:257–263. doi: 10.1097/TP.0b013e3181772a75. [DOI] [PubMed] [Google Scholar]
  • 18.Azevedo LS, Lasmar EP, Contieri FL, et al. Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter study. Transpl Infect Dis. 2012;14:237–241. doi: 10.1111/j.1399-3062.2011.00686.x. [DOI] [PubMed] [Google Scholar]
  • 19.Baas MC, Van Donselaar KA, Florquin S, et al. Mumps: not an innocent bystander in solid organ transplantation. Am J Transplant. 2009;9:2186–2189. doi: 10.1111/j.1600-6143.2009.02732.x. [DOI] [PubMed] [Google Scholar]
  • 20.Backhaus E, Berg S, Andersson R, et al. Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors. BMC Infect Dis. 2016;16:367. doi: 10.1186/s12879-016-1648-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Balmer P, Falconer M, Mcdonald P, et al. Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals. Infect Immun. 2004;72:332–337. doi: 10.1128/IAI.72.1.332-337.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Barra A, Cordonnier C, Preziosi MP, et al. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. J INFECT DIS. 1992;166:1021–1028. doi: 10.1093/infdis/166.5.1021. [DOI] [PubMed] [Google Scholar]
  • 23.Barton M, Wasfy S, Dipchand AI, et al. Seven-valent pneumococcal conjugate vaccine in pediatric solid organ transplant recipients: a prospective study of safety and immunogenicity. Pediatr Infect Dis J. 2009;28:688–692. doi: 10.1097/INF.0b013e31819d97be. [DOI] [PubMed] [Google Scholar]
  • 24.Bassetti M, Castaldo N, Carnelutti A. Neuraminidase inhibitors as a strategy for influenza treatment: pros, cons and future perspectives. Opinion on Pharmacotherapy: Expert; 2019. pp. 1–8. [DOI] [PubMed] [Google Scholar]
  • 25.Bastidas A, De La El Serna Idrissi JM, et al. Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial. JAMA. 2019;322:123–133. doi: 10.1001/jama.2019.9053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Bate J, Baker S, Breuer J, et al. PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer. Arch Dis Child. 2019;104:25–29. doi: 10.1136/archdischild-2017-314212. [DOI] [PubMed] [Google Scholar]
  • 27.Berglund A, Willen L, Grodeberg L, et al. The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab. Acta Oncol. 2014;53:1212–1220. doi: 10.3109/0284186X.2014.914243. [DOI] [PubMed] [Google Scholar]
  • 28.Berkowitz EM, Moyle G, Stellbrink HJ, et al. Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1/2a randomized, placebo-controlled study. J INFECT DIS. 2015;211:1279–1287. doi: 10.1093/infdis/jiu606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Bersanelli M, Buti S, De Giorgi U, et al. State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: When common sense is not enough. Crit Rev Oncol Hematol. 2019;139:87–90. doi: 10.1016/j.critrevonc.2019.05.003. [DOI] [PubMed] [Google Scholar]
  • 30.Bersanelli M, Giannarelli D, Castrignano P, et al. INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. Immunotherapy. 2018;10:1229–1239. doi: 10.2217/imt-2018-0080. [DOI] [PubMed] [Google Scholar]
  • 31.Bhatia S, Louie AD, Bhatia R, et al. Solid cancers after bone marrow transplantation. J Clin Oncol. 2001;19:464–471. doi: 10.1200/JCO.2001.19.2.464. [DOI] [PubMed] [Google Scholar]
  • 32.Bisharat N, Omari H, Lavi I, et al. Risk of infection and death among post-splenectomy patients. J Infect. 2001;43:182–186. doi: 10.1053/jinf.2001.0904. [DOI] [PubMed] [Google Scholar]
  • 33.Blevins LK, Wren JT, Holbrook BC, et al. Coinfection with Streptococcus pneumoniae negatively modulates the size and composition of the ongoing influenza-specific CD8(+) T cell response. J Immunol. 2014;193:5076–5087. doi: 10.4049/jimmunol.1400529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Blimark C, Holmberg E, Mellqvist UH, et al. Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients. Haematologica. 2015;100:107–113. doi: 10.3324/haematol.2014.107714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Bochennek K, Allwinn R, Langer R, et al. Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancer. Vaccine. 2014;32:3357–3361. doi: 10.1016/j.vaccine.2014.04.042. [DOI] [PubMed] [Google Scholar]
  • 36.Boeckh M, Kim HW, Flowers ME, et al. Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation—a randomized double-blind placebo-controlled study. Blood. 2006;107:1800–1805. doi: 10.1182/blood-2005-09-3624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Bonanni P, Grazzini M, Niccolai G, et al. Recommended vaccinations for asplenic and hyposplenic adult patients. Hum Vaccines Immunother. 2017;13:359–368. doi: 10.1080/21645515.2017.1264797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Branagan AR, Duffy E, Albrecht RA, et al. Clinical and Serologic Responses After a Two-dose Series of High-dose Influenza Vaccine in Plasma Cell Disorders: A Prospective, Single-arm Trial. Clin Lymphoma Myeloma Leuk. 2017;17:296–304.e292. doi: 10.1016/j.clml.2017.02.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Briere EC, Rubin L, Moro PL, et al. Prevention and control of haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recomm Reports. 2014;63:1–14. [PubMed] [Google Scholar]
  • 40.Bronte V, Pittet MJ. The spleen in local and systemic regulation of immunity. Immunity. 2013;39:806–818. doi: 10.1016/j.immuni.2013.10.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Broyer M, Tete MJ, Guest G, et al. Varicella and zoster in children after kidney transplantation: long-term results of vaccination. Pediatrics. 1997;99:35–39. doi: 10.1542/peds.99.1.35. [DOI] [PubMed] [Google Scholar]
  • 42.Brydak LB, Guzy J, Starzyk J, et al. Humoral immune response after vaccination against influenza in patients with breast cancer. Support Care Cancer. 2001;9:65–68. doi: 10.1007/s005200000186. [DOI] [PubMed] [Google Scholar]
  • 43.Burchard GD, Caumes E, Connor BA, et al. Expert opinion on vaccination of travelers against Japanese encephalitis. J Travel Med. 2009;16:204–216. doi: 10.1111/j.1708-8305.2009.00330.x. [DOI] [PubMed] [Google Scholar]
  • 44.Calaminus G, Hense B, Laws HJ, et al. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92. Klin Padiatr. 2007;219:355–360. doi: 10.1055/s-2007-990290. [DOI] [PubMed] [Google Scholar]
  • 45.Cameron PU, Jones P, Gorniak M, et al. Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohort. Plos One. 2011;6:e23164. doi: 10.1371/journal.pone.0023164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Canadian Immunization Guide: Part 3—Vaccination of Specific Population (2016) Immunization of Immunocompromised Persons. https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunizationguide-part-3-vaccination-specific-populations/page-8-immunization-immunocompromisedpersons.html#a15. Zugegriffen: 18. März 2020
  • 47.Carey W, Pimentel R, Westveer MK, et al. Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial. Am J Gastroenterol. 1990;85:1590–1592. [PubMed] [Google Scholar]
  • 48.Chakravarty EF, Murray ER, Kelman A, et al. Pregnancy outcomes after maternal exposure to rituximab. Blood. 2011;117:1499–1506. doi: 10.1182/blood-2010-07-295444. [DOI] [PubMed] [Google Scholar]
  • 49.Chalasani N, Smallwood G, Halcomb J, et al. Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation? Liver Transpl Surg. 1998;4:128–132. doi: 10.1002/lt.500040208. [DOI] [PubMed] [Google Scholar]
  • 50.Cheng MP, Pandit A, Antin JH, et al. Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantation. Blood Adv. 2018;2:1272–1276. doi: 10.1182/bloodadvances.2018018911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Chiou WY, Hung SK, Lai CL, et al. Effect of 23-Valent Pneumococcal Polysaccharide Vaccine Inoculated During Anti-Cancer Treatment Period in Elderly Lung Cancer Patients on Community-Acquired Pneumonia Hospitalization: A Nationwide Population-Based Cohort Study. Medicine. 2015;94:e1022. doi: 10.1097/MD.0000000000001022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Chitasombat MN, Watcharananan SP. Prevalence and Outcome of Disseminated Varicella Zoster Infection Post Kidney Transplantation. J Med Assoc Thai. 2016;99:381–385. [PubMed] [Google Scholar]
  • 53.Choi DK, Fuleihan RL, Walterhouse DO. Serologic response and clinical efficacy of influenza vaccination in children and young adults on chemotherapy for cancer. Pediatr Blood Cancer. 2016;63:2011–2018. doi: 10.1002/pbc.26110. [DOI] [PubMed] [Google Scholar]
  • 54.Chong CR, Park VJ, Cohen B, et al. Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors (ICI) Clin Infect Dis. 2019;70:193–199. doi: 10.1093/cid/ciz202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Chong J, Jones P, Spelman D, et al. Overwhelming post-splenectomy sepsis in patients with asplenia and hyposplenia: a retrospective cohort study. Epidemiol Infect. 2017;145:397–400. doi: 10.1017/S0950268816002405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Chung C. To do or not to do: A concise update of current clinical controversies in immune checkpoint blockade. J Oncol Pharm Pract. 2019;25:663–673. doi: 10.1177/1078155218786365. [DOI] [PubMed] [Google Scholar]
  • 57.Concepcion BP, Schaefer HM. Caring for the pregnant kidney transplant recipient. Clin Transplant. 2011;25:821–829. doi: 10.1111/j.1399-0012.2011.01492.x. [DOI] [PubMed] [Google Scholar]
  • 58.Copelovici Y, Strulovici D, Cristea AL, et al. Data on the efficiency of specific antimumps immunoglobulins in the prevention of mumps and of its complications. Virologie. 1979;30:171–177. [PubMed] [Google Scholar]
  • 59.Cordero E, Aydillo TA, Perez-Ordonez A, et al. Deficient long-term response to pandemic vaccine results in an insufficient antibody response to seasonal influenza vaccination in solid organ transplant recipients. Transplantation. 2012;93:847–854. doi: 10.1097/TP.0b013e318247a6ef. [DOI] [PubMed] [Google Scholar]
  • 60.Cordero E, Roca-Oporto C, Bulnes-Ramos A, et al. Two Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Results of TRANSGRIPE 1–2, a Randomized Controlled Clinical Trial. Clin Infect Dis. 2017;64:829–838. doi: 10.1093/cid/ciw855. [DOI] [PubMed] [Google Scholar]
  • 61.Cordonnier C, Einarsdottir S, Cesaro S, et al. Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7) Lancet Infect Dis. 2019;19:e200–e212. doi: 10.1016/S1473-3099(18)30600-5. [DOI] [PubMed] [Google Scholar]
  • 62.Cordonnier C, Labopin M, Chesnel V, et al. Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation. Clin Infect Dis. 2009;48:1392–1401. doi: 10.1086/598324. [DOI] [PubMed] [Google Scholar]
  • 63.Cordonnier C, Ljungman P, Juergens C, et al. Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged 〉/=2 years: an open-label study. Clin Infect Dis. 2015;61:313–323. doi: 10.1093/cid/civ287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Cornberg M, Protzer U, Petersen J, et al. Prophylaxis, diagnosis and therapy of hepatitis B virus infection—the German guideline. Z Gastroenterol. 2011;49:871–930. doi: 10.1055/s-0031-1273462. [DOI] [PubMed] [Google Scholar]
  • 65.Coscia LA, Constantinescu S, Armenti DP, et al. The 25th Anniversary of the National Transplantation Pregnancy Registry. Clin Transpl. 2015;31:57–68. [PubMed] [Google Scholar]
  • 66.Cramer CH, 2nd, Shieck V, Thomas SE, et al. Immune response to rabies vaccination in pediatric transplant patients. Pediatr Transplantation. 2008;12:874–877. doi: 10.1111/j.1399-3046.2008.00936.x. [DOI] [PubMed] [Google Scholar]
  • 67.Crawford NW, Balloch A, Tikkanen L, et al. Pneumococcal conjugate vaccine administration during therapy for pediatric leukemia. Pediatr Infect Dis J. 2015;34:e9–15. doi: 10.1097/INF.0000000000000502. [DOI] [PubMed] [Google Scholar]
  • 68.Croce E, Hatz C, Jonker EF, et al. Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation—A systematic review of randomized trials, observational studies and case reports. Vaccine. 2017;35:1216–1226. doi: 10.1016/j.vaccine.2017.01.048. [DOI] [PubMed] [Google Scholar]
  • 69.Dagnew AF, Ilhan O, Lee WS, et al. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis. Lancet Infect Dis. 2019;19:988–1000. doi: 10.1016/S1473-3099(19)30163-X. [DOI] [PubMed] [Google Scholar]
  • 70.Daneshpouy M, Socie G, Clavel C, et al. Human papillomavirus infection and anogenital condyloma in bone marrow transplant recipients. Transplantation. 2001;71:167–169. doi: 10.1097/00007890-200101150-00030. [DOI] [PubMed] [Google Scholar]
  • 71.Danziger-Isakov L, Kumar D. Vaccination in solid organ transplantation. Am J Transplant. 2013;13(4):311–317. doi: 10.1111/ajt.12122. [DOI] [PubMed] [Google Scholar]
  • 72.Danziger-Isakov L, Kumar D, Practice AICo Vaccination of Solid Organ Transplant Candidates and Recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33:e13563. doi: 10.1111/ctr.13563. [DOI] [PubMed] [Google Scholar]
  • 73.Davies JM, Lewis MP, Wimperis J, et al. Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology by a working party of the Haemato-Oncology task force. Br J Haematol. 2011;155:308–317. doi: 10.1111/j.1365-2141.2011.08843.x. [DOI] [PubMed] [Google Scholar]
  • 74.De Lavallade H, Garland P, Sekine T, et al. Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host. Haematologica. 2011;96:307–314. doi: 10.3324/haematol.2010.032664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.De Silva IGS, Cole J, Stone Bj, Dockrell Dh, Vedio A. Successful use of Fendrix in HIV-infected non-responders to standard hepatitis B vaccines. J Infect. 2014;68:397–399. doi: 10.1016/j.jinf.2013.12.009. [DOI] [PubMed] [Google Scholar]
  • 76.de Sousa MV, Zollner RL, Stucchi RSB, Boin I, de Ataide EC, Mazzali M. Yellow fever disease in a renal transplant recipient: Case report and literature review. Transpl Infect Dis. 2019;21:e13151. doi: 10.1111/tid.13151. [DOI] [PubMed] [Google Scholar]
  • 77.Decker M, Rothermundt C, Hollander G, et al. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. Lancet Oncol. 2006;7:693–694. doi: 10.1016/S1470-2045(06)70797-5. [DOI] [PubMed] [Google Scholar]
  • 78.Dekkiche S, de Valliere S, D'Acremont V, Genton B. Travel-related health risks in moderately and severely immunocompromised patients: a case-control study. J Travel Med. 2016 doi: 10.1093/jtm/taw001. [DOI] [PubMed] [Google Scholar]
  • 79.Den Haan JM, Kraal G. Innate immune functions of macrophage subpopulations in the spleen. J Innate Immun. 2012;4:437–445. doi: 10.1159/000335216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Dendle C, Stuart RL, Mulley WR, et al. Pneumococcal vaccination in adult solid organ transplant recipients: A review of current evidence. Vaccine. 2018;36:6253–6261. doi: 10.1016/j.vaccine.2018.08.069. [DOI] [PubMed] [Google Scholar]
  • 81.Dengler TJ, Zimmermann R, Meyer J, et al. Vaccination against tick-borne encephalitis under therapeutic immunosuppression. Reduced efficacy in heart transplant recipients. Vaccine. 1999;17:867–874. doi: 10.1016/s0264-410x(98)00272-2. [DOI] [PubMed] [Google Scholar]
  • 82.Deniset JF, Surewaard BG, Lee WY, et al. Splenic Ly6G(high) mature and Ly6G(int) immature neutrophils contribute to eradication of S. pneumoniae. J Exp Med. 2017;214:1333–1350. doi: 10.1084/jem.20161621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Di Cataldo A, Puleo S, Destri LG, et al. Splenic trauma and overwhelming postsplenectomy infection. Br J Surg. 1987;74:343–345. doi: 10.1002/bjs.1800740504. [DOI] [PubMed] [Google Scholar]
  • 84.Di Sabatino A, Carsetti R, Corazza GR. Post-splenectomy and hyposplenic states. Lancet. 2011;378:86–97. doi: 10.1016/S0140-6736(10)61493-6. [DOI] [PubMed] [Google Scholar]
  • 85.Diana A, Posfay-Barbe KM, Belli DC, et al. Vaccine-induced immunity in children after orthotopic liver transplantation: a 12-yr review of the Swiss national reference center. Pediatr Transplantation. 2007;11:31–37. doi: 10.1111/j.1399-3046.2006.00596.x. [DOI] [PubMed] [Google Scholar]
  • 86.Dinelli MIS, Dos SAMN, Weckx LY, et al. Safe administration of rotavirus vaccine in a cohort of infants exposed to immunosuppressive drugs during gestation. Transpl Infect Dis. 2018;20:e12951. doi: 10.1111/tid.12951. [DOI] [PubMed] [Google Scholar]
  • 87.Dos Santos G, Haguinet F, Cohet C, et al. Risk of solid organ transplant rejection following vaccination with seasonal trivalent inactivated influenza vaccines in England: A self-controlled case-series. Vaccine. 2016;34:3598–3606. doi: 10.1016/j.vaccine.2016.05.016. [DOI] [PubMed] [Google Scholar]
  • 88.Douglas AP, Trubiano JA, Barr I, et al. Ibrutinib may impair serological responses to influenza vaccination. Haematologica. 2017;102:e397–e399. doi: 10.3324/haematol.2017.164285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Dumont-Girard F, Roux E, Van Lier RA, et al. Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants. Blood. 1998;92:4464–4471. [PubMed] [Google Scholar]
  • 90.Dumot JA, Barnes DS, Younossi Z, et al. Immunogenicity of hepatitis A vaccine in decompensated liver disease. Am J Gastroenterol. 1999;94:1601–1604. doi: 10.1111/j.1572-0241.1999.01150.x. [DOI] [PubMed] [Google Scholar]
  • 91.Earle CC. Influenza vaccination in elderly patients with advanced colorectal cancer. J Clin Oncol. 2003;21:1161–1166. doi: 10.1200/JCO.2003.06.008. [DOI] [PubMed] [Google Scholar]
  • 92.Eckerle I, Rosenberger KD, Zwahlen M, et al. Serologic vaccination response after solid organ transplantation: a systematic review. Plos One. 2013;8:e56974. doi: 10.1371/journal.pone.0056974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Edgren G, Almqvist R, Hartman M, et al. Splenectomy and the risk of sepsis: a population-based cohort study. Ann Surg. 2014;260:1081–1087. doi: 10.1097/SLA.0000000000000439. [DOI] [PubMed] [Google Scholar]
  • 94.Ehl S, Bogdan C, Niehues T, et al. Impfen bei Immundefizienz: Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (II) Impfen bei 1. Primären Immundefekterkrankungen und 2. HIV-Infektion. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61:1034–1051. doi: 10.1007/s00103-018-2761-8. [DOI] [PubMed] [Google Scholar]
  • 95.Ejstrud P, Kristensen B, Hansen JB, et al. Risk and patterns of bacteraemia after splenectomy: a population-based study. Scand J Infect Dis. 2000;32:521–525. doi: 10.1080/003655400458811. [DOI] [PubMed] [Google Scholar]
  • 96.Ek T, Mellander L, Andersson B, et al. Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group. Pediatr Blood Cancer. 2005;44:461–468. doi: 10.1002/pbc.20255. [DOI] [PubMed] [Google Scholar]
  • 97.Ek T, Mellander L, Hahn-Zoric M, et al. Avidity of tetanus and Hib antibodies after childhood acute lymphoblastic leukaemia—implications for vaccination strategies. Acta Paediatr. 2006;95:701–706. doi: 10.1080/08035250500459717. [DOI] [PubMed] [Google Scholar]
  • 98.Ek T, Mellander L, Hahn-Zoric M, et al. Intensive treatment for childhood acute lymphoblastic leukemia reduces immune responses to diphtheria, tetanus, and Haemophilus influenzae type b. J Pediatr Hematol Oncol. 2004;26:727–734. doi: 10.1097/00043426-200411000-00008. [DOI] [PubMed] [Google Scholar]
  • 99.El Hoss S, Dussiot M, Renaud O, et al. A novel non-invasive method to measure splenic filtration function in humans. Haematologica. 2018;103:e436–e439. doi: 10.3324/haematol.2018.188920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Engelhard D, Cordonnier C, Shaw PJ, et al. Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey. Br J Haematol. 2002;117:444–450. doi: 10.1046/j.1365-2141.2002.03457.x. [DOI] [PubMed] [Google Scholar]
  • 101.Engelhard D, Mohty B, De La Camara R, et al. European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN. Transpl Infect Dis. 2013;15:219–232. doi: 10.1111/tid.12054. [DOI] [PubMed] [Google Scholar]
  • 102.Engelhard D, Zakay-Rones Z, Shapira MY, et al. The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic. Vaccine. 2011;29:1777–1782. doi: 10.1016/j.vaccine.2010.12.113. [DOI] [PubMed] [Google Scholar]
  • 103.Eperon GBS, Enriquez N, Vaudaux B. Voyageur immunosupprimé : recommandations vaccinales. Rev Med Suisse. 2018;14:922–933. [PubMed] [Google Scholar]
  • 104.Esposito S, Tenconi R, Preti V, et al. Chemotherapy against cancer during pregnancy: A systematic review on neonatal outcomes. Medicine. 2016;95:e4899. doi: 10.1097/MD.0000000000004899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.European Medicinces Agency (2018) Assessment Report—Shingrix.
  • 106.Eyrich M, Wiegering V, Lim A, et al. Immune function in children under chemotherapy for standard risk acute lymphoblastic leukaemia—a prospective study of 20 paediatric patients. Br J Haematol. 2009;147:360–370. doi: 10.1111/j.1365-2141.2009.07862.x. [DOI] [PubMed] [Google Scholar]
  • 107.Fabrizi F, Dixit V, Bunnapradist S, et al. Meta-analysis: the dialysis mode and immunological response to hepatitis B virus vaccine in dialysis population. Aliment Pharmacol Ther. 2006;23:1105–1112. doi: 10.1111/j.1365-2036.2006.02877.x. [DOI] [PubMed] [Google Scholar]
  • 108.Feldman S, Gigliotti F, Shenep JL, et al. Risk of Haemophilus influenzae type b disease in children with cancer and response of immunocompromised leukemic children to a conjugate vaccine. J INFECT DIS. 1990;161:926–931. doi: 10.1093/infdis/161.5.926. [DOI] [PubMed] [Google Scholar]
  • 109.Forstner C, Plefka S, Tobudic S, et al. Effectiveness and immunogenicity of pneumococcal vaccination in splenectomized and functionally asplenic patients. Vaccine. 2012;30:5449–5452. doi: 10.1016/j.vaccine.2012.06.048. [DOI] [PubMed] [Google Scholar]
  • 110.Galea SA, Sweet A, Beninger P, et al. The safety profile of varicella vaccine: a 10-year review. J INFECT DIS. 2008;197(2):165–169. doi: 10.1086/522125. [DOI] [PubMed] [Google Scholar]
  • 111.Gandhi MK, Egner W, Sizer L, et al. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients. Bone Marrow Transplant. 2001;28:775–781. doi: 10.1038/sj.bmt.1703239. [DOI] [PubMed] [Google Scholar]
  • 112.Garcia Garrido HM, Veurink AM, Leeflang M, Spijker R, Goorhuis A, Grobusch MP. Hepatitis A vaccine immunogenicity in patients using immunosuppressive drugs: A systematic review and meta-analysis. Travel Med Infect Dis. 2019 doi: 10.1016/j.tmaid.2019.101479. [DOI] [PubMed] [Google Scholar]
  • 113.Garcia Garrido HM, Wieten RW, Grobusch MP, et al. Response to Hepatitis A Vaccination in Immunocompromised Travelers. J INFECT DIS. 2015;212:378–385. doi: 10.1093/infdis/jiv060. [DOI] [PubMed] [Google Scholar]
  • 114.Geretti AM, Brook G, Cameron C, et al. British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015. HIV Med. 2016;17(3):2–81. doi: 10.1111/hiv.12424. [DOI] [PubMed] [Google Scholar]
  • 115.Gil L, Styczynski J, Komarnicki M. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome. Infection. 2007;35:421–427. doi: 10.1007/s15010-007-6350-2. [DOI] [PubMed] [Google Scholar]
  • 116.Gollwitzer ES, Marsland BJ. Impact of Early-Life Exposures on Immune Maturation and Susceptibility to Disease. Trends Immunol. 2015;36:684–696. doi: 10.1016/j.it.2015.09.009. [DOI] [PubMed] [Google Scholar]
  • 117.Goossen GM, Kremer LC, van de Wetering MD. Influenza vaccination in children being treated with chemotherapy for cancer. Cochrane Database Syst Rev. 2013 doi: 10.1002/14651858.CD006484.pub3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Gordon MA. Salmonella infections in immunocompromised adults. J Infect. 2008;56:413–422. doi: 10.1016/j.jinf.2008.03.012. [DOI] [PubMed] [Google Scholar]
  • 119.Gowda R, Cartwright K, Bremner JA, et al. Yellow fever vaccine: a successful vaccination of an immunocompromised patient. Eur J Haematol. 2004;72:299–301. doi: 10.1111/j.1600-0609.2004.00218.x. [DOI] [PubMed] [Google Scholar]
  • 120.Greenwood KP, Hafiz R, Ware RS, et al. A systematic review of human-to-human transmission of measles vaccine virus. Vaccine. 2016;34:2531–2536. doi: 10.1016/j.vaccine.2016.03.092. [DOI] [PubMed] [Google Scholar]
  • 121.Gsk (2019) Rabipur – Fachinformation.
  • 122.Gunther M, Neuhaus R, Bauer T, et al. Immunization with an adjuvant hepatitis B vaccine in liver transplant recipients: antibody decline and booster vaccination with conventional vaccine. Liver Transpl. 2006;12:316–319. doi: 10.1002/lt.20674. [DOI] [PubMed] [Google Scholar]
  • 123.Gunther M, Stark K, Neuhaus R, et al. Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation. 2001;71:477–479. doi: 10.1097/00007890-200102150-00023. [DOI] [PubMed] [Google Scholar]
  • 124.Gwyn K. Children Exposed to Chemotherapy In Utero. Jnci Monogr. 2005;2005:69–71. doi: 10.1093/jncimonographs/lgi009. [DOI] [PubMed] [Google Scholar]
  • 125.Gwynn ME, DeRemer DL, Saunders KM, Parikh J, Bollag RJ, Clemmons AB. Immune-mediated adverse events following influenza vaccine in cancer patients receiving immune checkpoint inhibitors. J Oncol Pharm Pract. 2019 doi: 10.1177/1078155219868758. [DOI] [PubMed] [Google Scholar]
  • 126.Hakim H, Dallas R, Zhou Y, et al. Acute respiratory infections in children and adolescents with acute lymphoblastic leukemia. Cancer. 2016;122:798–805. doi: 10.1002/cncr.29833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Halasa NB, Shankar SM, Talbot TR, et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2007;44:1428–1433. doi: 10.1086/516781. [DOI] [PubMed] [Google Scholar]
  • 128.Hamaguchi Y, Mori A, Uemura T, et al. Incidence and risk factors for herpes zoster in patients undergoing liver transplantation. Transpl Infect Dis. 2015;17:671–678. doi: 10.1111/tid.12425. [DOI] [PubMed] [Google Scholar]
  • 129.Han CS, Miller W, Haake R, et al. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications. Bone Marrow Transplant. 1994;13:277–283. [PubMed] [Google Scholar]
  • 130.Hansson KE, Rosdahl A, Insulander M, et al. Tick-borne Encephalitis Vaccine Failures: A 10-year Retrospective Study Supporting the Rationale for Adding an Extra Priming Dose in Individuals Starting at Age 50 Years. Clin Infect Dis. 2020;70:245–251. doi: 10.1093/cid/ciz176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131.Haut Conseil De La Santé Publique (2014) Vaccination des personnes immunodéprimées ou aspléniques—Recommandations.
  • 132.Hayakawa K, Takasaki T, Tsunemine H, et al. Persistent seropositivity for yellow fever in a previously vaccinated autologous hematopoietic stem cell transplantation recipient. Int J Infect Dis. 2015;37:9–10. doi: 10.1016/j.ijid.2015.05.025. [DOI] [PubMed] [Google Scholar]
  • 133.Helou E, Grant M, Landry M, Wu X, Morrow JS, Malinis MF. Fatal case of cutaneous-sparing orolaryngeal zoster in a renal transplant recipient. Transpl Infect Dis. 2017 doi: 10.1111/tid.12704. [DOI] [PubMed] [Google Scholar]
  • 134.Hernandez MC, Khasawneh M, Contreras-Peraza N, et al. Vaccination and splenectomy in Olmsted County. Surgery. 2019;166:556–563. doi: 10.1016/j.surg.2019.04.046. [DOI] [PubMed] [Google Scholar]
  • 135.Hertzell KB, Pauksens K, Rombo L, et al. Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study. Vaccine. 2016;34:650–655. doi: 10.1016/j.vaccine.2015.12.029. [DOI] [PubMed] [Google Scholar]
  • 136.Hilgendorf I, Freund M, Jilg W, et al. Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD. Vaccine. 2011;29:2825–2833. doi: 10.1016/j.vaccine.2011.02.018. [DOI] [PubMed] [Google Scholar]
  • 137.Holdsworth RJ, Irving AD, Cuschieri A. Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg. 1991;78:1031–1038. doi: 10.1002/bjs.1800780904. [DOI] [PubMed] [Google Scholar]
  • 138.Hung TY, Kotecha RS, Blyth CC, et al. Immunogenicity and safety of single-dose, 13-valent pneumococcal conjugate vaccine in pediatric and adolescent oncology patients. Cancer. 2017;123:4215–4223. doi: 10.1002/cncr.30764. [DOI] [PubMed] [Google Scholar]
  • 139.Hurst FP, Lee JJ, Jindal RM, et al. Outcomes associated with influenza vaccination in the first year after kidney transplantation. Clin J Am Soc Nephrol. 2011;6:1192–1197. doi: 10.2215/CJN.05430610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140.Huzly D, Neifer S, Reinke P, et al. Routine immunizations in adult renal transplant recipients. Transplantation. 1997;63:839–845. doi: 10.1097/00007890-199703270-00008. [DOI] [PubMed] [Google Scholar]
  • 141.Ilan Y, Nagler A, Zeira E, et al. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients. Bone Marrow Transplant. 2000;26:633–638. doi: 10.1038/sj.bmt.1702571. [DOI] [PubMed] [Google Scholar]
  • 142.Inaba H, Hartford CM, Pei D, et al. Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2012;156:109–117. doi: 10.1111/j.1365-2141.2011.08913.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 143.Ison MG, Szakaly P, Shapira MY, et al. Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients. Antivir Ther. 2012;17:955–964. doi: 10.3851/IMP2192. [DOI] [PubMed] [Google Scholar]
  • 144.Ito K, Mugitani A, Irie S, et al. Prior vaccinations improve immunogenicity of inactivated influenza vaccine in young children aged 6 months to 3 years: A cohort study. Medicine. 2018;97:e11551. doi: 10.1097/MD.0000000000011551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 145.Jeon HJ, Ro H, Jeong JC, et al. Efficacy and safety of hepatitis A vaccination in kidney transplant recipients. Transpl Infect Dis. 2014;16:511–515. doi: 10.1111/tid.12217. [DOI] [PubMed] [Google Scholar]
  • 146.Jochems SP, Marcon F, Carniel BF, et al. Inflammation induced by influenza virus impairs human innate immune control of pneumococcus. Nat Immunol. 2018;19:1299–1308. doi: 10.1038/s41590-018-0231-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147.Jonker EF, Visser LG, Roukens AH. Advances and controversies in yellow fever vaccination. Ther Adv Vaccines. 2013;1:144–152. doi: 10.1177/2051013613498954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148.Jonker EFF, Uijlings Visser MCLG, et al. Comparison of the immunogenicity of Dukoral(R) oral cholera vaccine between renal transplant recipients on either a calcineurin inhibitor or mycophenolate—A controlled trial. Vaccine. 2019;37:3133–3139. doi: 10.1016/j.vaccine.2019.04.010. [DOI] [PubMed] [Google Scholar]
  • 149.Kaatsch PGD, Spix C. Deutsches Kinderkrebsregister. Mainz: Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI) at the University Medical Center of the Johannes Gutenberg University; 2019. German Childhood Cancer Registry—Annual Report 2018 (1980–2017) [Google Scholar]
  • 150.Kamboj M, Shah MK. Vaccination of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient. Infect Dis Clin North Am. 2019;33:593–609. doi: 10.1016/j.idc.2019.02.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 151.Kanda Y, Mineishi S, Saito T, et al. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;28:689–692. doi: 10.1038/sj.bmt.1703214. [DOI] [PubMed] [Google Scholar]
  • 152.Kang G, Chen H, Ma F, et al. Comparison of the effect of increased hepatitis B vaccine dosage on immunogenicity in healthy children and adults. Hum Vaccines Immunother. 2016;12:2312–2316. doi: 10.1080/21645515.2016.1172757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 153.Kang M, Aslam S. Varicella zoster virus encephalitis in solid organ transplant recipients: Case series and review of literature. Transpl Infect Dis. 2019;21:e13038. doi: 10.1111/tid.13038. [DOI] [PubMed] [Google Scholar]
  • 154.Kano H, Mizuta K, Sakakihara Y, et al. Efficacy and safety of immunization for pre- and post-liver transplant children. Transplantation. 2002;74:543–550. doi: 10.1097/00007890-200208270-00020. [DOI] [PubMed] [Google Scholar]
  • 155.Kaul A, Sharma RK, Bhadhuria D, et al. Chickenpox infection after renal transplantation. Clin Kidney J. 2012;5:203–206. doi: 10.1093/ckj/sfs036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 156.Kavaliotis J, Loukou I, Trachana M, et al. Outbreak of varicella in a pediatric oncology unit. Med Pediatr Oncol. 1998;31:166–169. doi: 10.1002/(sici)1096-911x(199809)31:3<166::aid-mpo7>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  • 157.Kawamura K, Yamazaki R, Akahoshi Y, et al. Evaluation of the immune status against measles, mumps, and rubella in adult allogeneic hematopoietic stem cell transplantation recipients. Hematology. 2015;20:77–82. doi: 10.1179/1607845414Y.0000000174. [DOI] [PubMed] [Google Scholar]
  • 158.Kawano Y, Suzuki M, Kawada J, et al. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients. Vaccine. 2015;33:1440–1445. doi: 10.1016/j.vaccine.2015.01.075. [DOI] [PubMed] [Google Scholar]
  • 159.Kidd IM, Booth CJ, Rigden SP, et al. Measles-associated encephalitis in children with renal transplants: a predictable effect of waning herd immunity? Lancet. 2003;362:832. doi: 10.1016/s0140-6736(03)14256-0. [DOI] [PubMed] [Google Scholar]
  • 160.Kim DK, Riley LE, Harriman KH, et al. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older—United States, 2017. Mmwr Morb Mortal Wkly Rep. 2017;66:136–138. doi: 10.15585/mmwr.mm6605e2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 161.Kim W, Kim S, Oh J, et al. Incidence and risk factors for herpes zoster after adult liver transplantation. Ann Surg Treat Res. 2019;96:95–99. doi: 10.4174/astr.2019.96.2.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 162.Kimby E, Sverrisdottir A, Elinder G. Safety of rituximab therapy during the first trimester of pregnancy: A case history. Eur J Haematol. 2004;72:292–295. doi: 10.1111/j.1600-0609.2004.00214.x. [DOI] [PubMed] [Google Scholar]
  • 163.Kling K, Wichmann O, Burchard G. Reiseimpfungen für besondere Personengruppen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020;63:85–92. doi: 10.1007/s00103-019-03067-w. [DOI] [PubMed] [Google Scholar]
  • 164.Klink DT, Van Elburg RM, Schreurs MW, et al. Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development. Clin Dev Immunol. 2008;2008:271363. doi: 10.1155/2008/271363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 165.Knight A, Pauksens K, Nordmark G, et al. Fatal outcome of tick-borne encephalitis in two patients with rheumatic disease treated with rituximab. Rheumatology. 2017;56:855–856. doi: 10.1093/rheumatology/kew495. [DOI] [PubMed] [Google Scholar]
  • 166.Koc Y, Miller KB, Schenkein DP, et al. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol Blood Marrow Transplant. 2000;6:44–49. doi: 10.1016/s1083-8791(00)70051-6. [DOI] [PubMed] [Google Scholar]
  • 167.Koo S, Gagne LS, Lee P, et al. Incidence and risk factors for herpes zoster following heart transplantation. Transpl Infect Dis. 2014;16:17–25. doi: 10.1111/tid.12149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 168.Kopel E, Oren G, Sidi Y, et al. Inadequate antibody response to rabies vaccine in immunocompromised patient. Emerging Infect Dis. 2012;18:1493–1495. doi: 10.3201/eid1809.111833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 169.Kotton CN. Vaccination and immunization against travel-related diseases in immunocompromised hosts. Expert Rev Vaccines. 2008;7:663–672. doi: 10.1586/14760584.7.5.663. [DOI] [PubMed] [Google Scholar]
  • 170.Kotton CNKA, Freedman DO. Travelers with Additional Considerations - Immunocompromised Travelers. In: Brunette GWNJ, editor. CDC Yellow Book 2020: Health Information for International Travel. New York: Oxford University Press; 2020. [Google Scholar]
  • 171.Barnes B, Kraywinkel K, Nowossadeck E, et al. Bericht zum Krebsgeschehen in Deutschland 2016. Berlin: Robert Koch-Institut; 2016. [Google Scholar]
  • 172.Kristensen K. Antibody response to a Haemophilus influenzae type b polysaccharide tetanus toxoid conjugate vaccine in splenectomized children and adolescents. Scand J Infect Dis. 1992;24:629–632. doi: 10.3109/00365549209054649. [DOI] [PubMed] [Google Scholar]
  • 173.Kristinsson SY, Gridley G, Hoover RN, et al. Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up. Haematologica. 2014;99:392–398. doi: 10.3324/haematol.2013.092460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 174.Kroger AT, Sumaya CV, Pickering LK, et al. General recommendations on immunization—recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recomm Reports. 2011;60:1–64. [PubMed] [Google Scholar]
  • 175.Kroon FP, Van Dissel JT, Labadie J, et al. Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus. Clin Infect Dis. 1995;21:1197–1203. doi: 10.1093/clinids/21.5.1197. [DOI] [PubMed] [Google Scholar]
  • 176.Kuchar E, Miskiewicz K, Karlikowska M. A review of guidance on immunization in persons with defective or deficient splenic function. Br J Haematol. 2015;171:683–694. doi: 10.1111/bjh.13660. [DOI] [PubMed] [Google Scholar]
  • 177.Kulkarni S, Powles R, Treleaven J, et al. Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants. Blood. 2000;95:3683–3686. [PubMed] [Google Scholar]
  • 178.Kumar A, Moulik NR, Verma N. Successful prevention of varicella outbreak in an overcrowded paediatric oncology ward using oral acyclovir prophylaxis. J Trop Pediatr. 2015;61:151. doi: 10.1093/tropej/fmv008. [DOI] [PubMed] [Google Scholar]
  • 179.Kumar D, Blumberg EA, Danziger-Isakov L, et al. Influenza vaccination in the organ transplant recipient: review and summary recommendations. Am J Transplant. 2011;11:2020–2030. doi: 10.1111/j.1600-6143.2011.03753.x. [DOI] [PubMed] [Google Scholar]
  • 180.Kumar D, Humar A, Plevneshi A, et al. Invasive pneumococcal disease in solid organ transplant recipients—10-year prospective population surveillance. Am J Transplant. 2007;7:1209–1214. doi: 10.1111/j.1600-6143.2006.01705.x. [DOI] [PubMed] [Google Scholar]
  • 181.Kumar D, Humar A, Plevneshi A, et al. Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance. Bone Marrow Transplant. 2008;41:743–747. doi: 10.1038/sj.bmt.1705964. [DOI] [PubMed] [Google Scholar]
  • 182.Kumar D, Michaels MG, Morris MI, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. The Lancet. Infect Dis. 2010;10:521–526. doi: 10.1016/S1473-3099(10)70133-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 183.Kyaw MH, Holmes EM, Toolis F, et al. Evaluation of severe infection and survival after splenectomy. Am J Med. 2006;119(276):e271–277. doi: 10.1016/j.amjmed.2005.07.044. [DOI] [PubMed] [Google Scholar]
  • 184.L’huillier AG, Kumar D. Immunizations in solid organ and hematopoeitic stem cell transplant patients: A comprehensive review. Hum Vaccines Immunother. 2015;11:2852–2863. doi: 10.1080/21645515.2015.1078043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 185.L’huillier AG, Posfay BK. Live viral vaccines in transplanted patients. Swiss Med Wkly. 2014;144:w14005. doi: 10.4414/smw.2014.14005. [DOI] [PubMed] [Google Scholar]
  • 186.La Nasa M, Gaughan J, Cardonick E. Incidence of Neonatal Neutropenia and Leukopenia After In Utero Exposure to Chemotherapy for Maternal Cancer. Am J Clin Oncol. 2019;42:351–354. doi: 10.1097/COC.0000000000000527. [DOI] [PubMed] [Google Scholar]
  • 187.Langley JM, Dodds L, Fell D, et al. Pneumococcal and influenza immunization in asplenic persons: a retrospective population-based cohort study 1990–2002. BMC Infect Dis. 2010;10:219. doi: 10.1186/1471-2334-10-219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 188.Läubli H, Balmelli C, Kaufmann L, et al. Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events. J Immunother Cancer. 2018;6:40–40. doi: 10.1186/s40425-018-0353-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 189.Laws HJ, Calaminus G, Gobel U. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Cancer. 2005;103:1759. doi: 10.1002/cncr.21017. [DOI] [PubMed] [Google Scholar]
  • 190.Laws HJ, Simon A, Lehrnbecher T. Revaccination in Children Undergoing Autologous Hematopoietic Stem Cell Transplantation: Results of a Survey in Germany, Austria and Switzerland. Klin Padiatr. 2019;231:136–141. doi: 10.1055/a-0796-6719. [DOI] [PubMed] [Google Scholar]
  • 191.Le Corre N, Thibault F, Pouteil NC, et al. Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial. Vaccine. 2012;30:7522–7528. doi: 10.1016/j.vaccine.2012.10.047. [DOI] [PubMed] [Google Scholar]
  • 192.Lehrnbecher T, Foster C, Vazquez N, et al. Therapy-induced alterations in host defense in children receiving therapy for cancer. J Pediatr Hematol Oncol. 1997;19:399–417. doi: 10.1097/00043426-199709000-00001. [DOI] [PubMed] [Google Scholar]
  • 193.Lehrnbecher T, Schubert R, Allwinn R, et al. Revaccination of children after completion of standard chemotherapy for acute lymphoblastic leukaemia: a pilot study comparing different schedules. Br J Haematol. 2011;152:754–757. doi: 10.1111/j.1365-2141.2010.08522.x. [DOI] [PubMed] [Google Scholar]
  • 194.Lehrnbecher T, Schubert R, Behl M, et al. Impaired pneumococcal immunity in children after treatment for acute lymphoblastic leukaemia. Br J Haematol. 2009;147:700–705. doi: 10.1111/j.1365-2141.2009.07903.x. [DOI] [PubMed] [Google Scholar]
  • 195.Leone G, Pizzigallo E. Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic Diseases. Mediterr J Hematol Infect Dis. 2015;7:e2015057. doi: 10.4084/MJHID.2015.057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 196.Lewensohn-Fuchs I, Ljungman P, Kjerrstrom A, et al. Loss of seroreactivity against human papillomavirus (HPV) in bone marrow transplant recipients. Bone Marrow Transplant. 1996;18:333–337. [PubMed] [Google Scholar]
  • 197.Lin KY, Chen GJ, Lee YL, et al. Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review. WJG. 2017;23:3589–3606. doi: 10.3748/wjg.v23.i20.3589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 198.Lindemann M, Heinemann FM, Horn PA, et al. Long-term response to vaccination against pneumococcal antigens in kidney transplant recipients. Transplantation. 2012;94:50–56. doi: 10.1097/TP.0b013e318250fc8c. [DOI] [PubMed] [Google Scholar]
  • 199.Lindstrom V, Aittoniemi J, Lyytikainen O, et al. Invasive pneumococcal disease in patients with haematological malignancies before routine use of conjugate vaccines in Finland. Infect Dis. 2016;48:399–402. doi: 10.3109/23744235.2015.1115894. [DOI] [PubMed] [Google Scholar]
  • 200.Linet MS, Nyren O, Gridley G, et al. Causes of death among patients surviving at least one year following splenectomy. Am J Surg. 1996;172:320–323. doi: 10.1016/S0002-9610(96)00196-1. [DOI] [PubMed] [Google Scholar]
  • 201.Linnemann CC, Jr., First MR. Risk of pneumococcal infections in renal transplant patients. JAMA. 1979;241:2619–2621. [PubMed] [Google Scholar]
  • 202.Linnemann CC, Jr., First MR, Schiffman G. Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine. Arch Intern Med. 1986;146:1554–1556. [PubMed] [Google Scholar]
  • 203.Lipowski D, Popiel M, Perlejewski K, et al. A Cluster of Fatal Tick-borne Encephalitis Virus Infection in Organ Transplant Setting. J INFECT DIS. 2017;215:896–901. doi: 10.1093/infdis/jix040. [DOI] [PubMed] [Google Scholar]
  • 204.Ljungman P, Aschan J, Barkholt L, et al. Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease. Bone Marrow Transplant. 2004;34:589–593. doi: 10.1038/sj.bmt.1704634. [DOI] [PubMed] [Google Scholar]
  • 205.Ljungman P, Avetisyan G. Influenza vaccination in hematopoietic SCT recipients. Bone Marrow Transplant. 2008;42:637–641. doi: 10.1038/bmt.2008.264. [DOI] [PubMed] [Google Scholar]
  • 206.Ljungman P, Cordonnier C, Einsele H, et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant. 2009;44:521–526. doi: 10.1038/bmt.2009.263. [DOI] [PubMed] [Google Scholar]
  • 207.Ljungman P, Ward KN, Crooks BN, et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2001;28:479–484. doi: 10.1038/sj.bmt.1703139. [DOI] [PubMed] [Google Scholar]
  • 208.Loftus MJ, Yong MK, Wilson S, Peleg AY. Fatal disseminated visceral varicella zoster virus infection in a renal transplant recipient. Transpl Infect Dis. 2019;21:e13062. doi: 10.1111/tid.13062. [DOI] [PubMed] [Google Scholar]
  • 209.Lopez-Gigosos RM, Segura M, Mariscal-Lopez E, Gutierrez-Bedmar M, Mariscal A. Prevalence of Chronic Diseases among International Travelers Seeking Pretravel Medical Advice in 2018 at Malaga, Spain. Am J Trop Med Hyg. 2020;102:684–688. doi: 10.4269/ajtmh.19-0702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 210.Lopez A, Mariette X, Bachelez H, et al. Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis. J Autoimmun. 2017;80:10–27. doi: 10.1016/j.jaut.2017.03.011. [DOI] [PubMed] [Google Scholar]
  • 211.Macartney K, Heywood A, McIntyre P. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Database Syst Rev. 2014 doi: 10.1002/14651858.CD001833.pub3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 212.MacIntyre CR, Shaw PJ, Mackie FE, et al. Long term follow up of persistence of immunity following quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children. Vaccine. 2019;37:5630–5636. doi: 10.1016/j.vaccine.2019.07.072. [DOI] [PubMed] [Google Scholar]
  • 213.Mackall C, Fry T, Gress R, et al. Background to hematopoietic cell transplantation, including post transplant immune recovery. Bone Marrow Transplant. 2009;44:457–462. doi: 10.1038/bmt.2009.255. [DOI] [PubMed] [Google Scholar]
  • 214.Mackall CL, Fleisher TA, Brown MR, et al. Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood. 1997;89:3700–3707. [PubMed] [Google Scholar]
  • 215.Mackay HJ, Mcgee J, Villa D, et al. Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatment. J Clin Virol. 2011;50:212–216. doi: 10.1016/j.jcv.2010.11.013. [DOI] [PubMed] [Google Scholar]
  • 216.Macneil JR, Rubin LG, Patton M, et al. Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons—Advisory Committee on Immunization Practices, 2016. Mmwr Morb Mortal Wkly Rep. 2016;65:1189–1194. doi: 10.15585/mmwr.mm6543a3. [DOI] [PubMed] [Google Scholar]
  • 217.Madenci AL, Armstrong LB, Kwon NK, et al. Incidence and risk factors for sepsis after childhood splenectomy. J Pediatr Surg. 2019;54:1445–1448. doi: 10.1016/j.jpedsurg.2018.06.024. [DOI] [PubMed] [Google Scholar]
  • 218.Madhi SA, Klugman KP. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med. 2004;10:811–813. doi: 10.1038/nm1077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 219.Mahler MB, Taur Y, Jean R, et al. Safety and immunogenicity of the tetravalent protein-conjugated meningococcal vaccine (MCV4) in recipients of related and unrelated allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2012;18:145–149. doi: 10.1016/j.bbmt.2011.07.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 220.Manistarski M, Levin D, Dvir R, et al. Lessons From an Outbreak of Varicella Infection in Pediatric Hemato-oncology Patients. Pediatr Infect Dis J. 2018;37:649–653. doi: 10.1097/INF.0000000000001920. [DOI] [PubMed] [Google Scholar]
  • 221.Mannick JB, Del Giudice G, Lattanzi M, et al. mTOR inhibition improves immune function in the elderly. Sci Transl Med. 2014;6:268ra179. doi: 10.1126/scitranslmed.3009892. [DOI] [PubMed] [Google Scholar]
  • 222.Manuel O, Kumar D, Singer LG, et al. Incidence and clinical characteristics of herpes zoster after lung transplantation. J Heart Lung Transplant : Off Publ Int Soc Heart Transplant. 2008;27:11–16. doi: 10.1016/j.healun.2007.09.028. [DOI] [PubMed] [Google Scholar]
  • 223.Martino R, Porras RP, Rabella N, et al. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transplant. 2005;11:781–796. doi: 10.1016/j.bbmt.2005.07.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 224.Martire B, Azzari C, Badolato R, et al. Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET) Vaccine. 2018;36:3541–3554. doi: 10.1016/j.vaccine.2018.01.061. [DOI] [PubMed] [Google Scholar]
  • 225.Mazzuoccolo LD, Andrada R, Pellerano G, et al. Levels of cyclosporine in breast milk and passage into the circulation of the infant of a mother with psoriasis. Int J Dermatol. 2014;53:355–356. doi: 10.1111/j.1365-4632.2012.05534.x. [DOI] [PubMed] [Google Scholar]
  • 226.Mebius RE, Kraal G. Structure and function of the spleen. Nature reviews. Immunology. 2005;5:606–616. doi: 10.1038/nri1669. [DOI] [PubMed] [Google Scholar]
  • 227.Meerveld-Eggink A, De Weerdt O, De Voer RM, et al. Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients. Eur J Clin Microbiol Infect Dis : Off Publ Eur Soc Clin Microbiol. 2011;30:611–618. doi: 10.1007/s10096-010-1129-2. [DOI] [PubMed] [Google Scholar]
  • 228.Meerveld-Eggink A, De Weerdt O, Van Der Velden AM, et al. Response to influenza virus vaccination during chemotherapy in patients with breast cancer. Ann Oncol : Off J Eur Soc Med Oncol. 2011;22:2031–2035. doi: 10.1093/annonc/mdq728. [DOI] [PubMed] [Google Scholar]
  • 229.Meerveld-Eggink A, De Weerdt O, Van Velzen-Blad H, et al. Response to conjugate pneumococcal and Haemophilus influenzae type b vaccines in asplenic patients. Vaccine. 2011;29:675–680. doi: 10.1016/j.vaccine.2010.11.034. [DOI] [PubMed] [Google Scholar]
  • 230.Mehta RS, Rezvani K. Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection. Virulence. 2016;7:901–916. doi: 10.1080/21505594.2016.1208866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 231.Meisel R, Kuypers L, Gruhn B, et al. Coadministration of the Hexavalent Combination Vaccine Infanrix hexa™ and the Pneumoccoccal Conjugate Vaccine Prevenar™ Provides Early and Comprehensive Vaccination Coverage in Children after Related and Unrelated Allogeneic Hematopoietic Stem Cell Transplantation. Blood. 2007;110:164–164. doi: 10.1182/blood-2006-06-032284. [DOI] [PubMed] [Google Scholar]
  • 232.Meisel R, Toschke AM, Heiligensetzer C, et al. Increased risk for invasive pneumococcal diseases in children with acute lymphoblastic leukaemia. Br J Haematol. 2007;137:457–460. doi: 10.1111/j.1365-2141.2007.06601.x. [DOI] [PubMed] [Google Scholar]
  • 233.Mikoluc B, Kayhty H, Bernatowska E, et al. Immune response to the 7-valent pneumococcal conjugate vaccine in 30 asplenic children. Eur J Clin Microbiol Infect Dis : Off Publ Eur Soc Clin Microbiol. 2008;27:923–928. doi: 10.1007/s10096-008-0523-5. [DOI] [PubMed] [Google Scholar]
  • 234.Mikoluc B, Motkowski R, Kayhty H, et al. Antibody response to Haemophilus influenzae type-b conjugate vaccine in children and young adults with congenital asplenia or after undergoing splenectomy. Eur J Clin Microbiol Infect Dis : Off Publ Eur Soc Clin Microbiol. 2012;31:805–809. doi: 10.1007/s10096-011-1378-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 235.Mikulska M, Cesaro S, de Lavallade H, et al. Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7) Lancet Infect Dis. 2019;19:e188–e199. doi: 10.1016/S1473-3099(18)30601-7. [DOI] [PubMed] [Google Scholar]
  • 236.Mina MJ, Klugman KP. The role of influenza in the severity and transmission of respiratory bacterial disease. Lancet Respir Med. 2014;2:750–763. doi: 10.1016/S2213-2600(14)70131-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 237.Miyairi I, Funaki T, Saitoh A. Immunization practices in solid organ transplant recipients. Vaccine. 2016;34:1958–1964. doi: 10.1016/j.vaccine.2016.03.001. [DOI] [PubMed] [Google Scholar]
  • 238.Molica S. Infections in chronic lymphocytic leukemia: risk factors, and impact on survival, and treatment. Leuk Lymphoma. 1994;13:203–214. doi: 10.3109/10428199409056283. [DOI] [PubMed] [Google Scholar]
  • 239.Molrine DC, Guinan EC, Antin JH, et al. Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation. Blood. 1996;87:3012–3018. [PubMed] [Google Scholar]
  • 240.Moore SM, Hanlon CA. Rabies-specific antibodies: measuring surrogates of protection against a fatal disease. PLoS Negl Trop Dis. 2010;4:e595. doi: 10.1371/journal.pntd.0000595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 241.Morrison VA. Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches. Best practice & research. Baillieres Clin Haematol. 2010;23:145–153. doi: 10.1016/j.beha.2009.12.004. [DOI] [PubMed] [Google Scholar]
  • 242.Mulder SF, Jacobs JF, Nordkamp OMA, et al. Cancer patients treated with sunitinib or sorafenib have sufficient antibody and cellular immune responses to warrant influenza vaccination. Clin Cancer Res. 2011;17:4541–4549. doi: 10.1158/1078-0432.CCR-11-0253. [DOI] [PubMed] [Google Scholar]
  • 243.Mulley WR, Dendle C, Ling JEH, et al. Does vaccination in solid-organ transplant recipients result in adverse immunologic sequelae? A systematic review and meta-analysis. J Heart Lung Transplant : Off Publ Int Soc Heart Transplant. 2018;37:844–852. doi: 10.1016/j.healun.2018.03.001. [DOI] [PubMed] [Google Scholar]
  • 244.Musto P, Carotenuto M. Vaccination against influenza in multiple myeloma. Br J Haematol. 1997;97:505–506. [PubMed] [Google Scholar]
  • 245.Na R, Grulich AE, Meagher NS, et al. Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients. Am J Transplant. 2013;13:174–183. doi: 10.1111/j.1600-6143.2012.04302.x. [DOI] [PubMed] [Google Scholar]
  • 246.Niehues T, Bogdan C, Hecht J, et al. Impfen bei Immundefizienz: Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (I) Grundlagenpapier. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017;60:674–684. doi: 10.1007/s00103-017-2555-4. [DOI] [PubMed] [Google Scholar]
  • 247.Nishio M, Fujimoto K, Yamamoto S, et al. Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphoma. Eur J Haematol. 2006;77:226–232. doi: 10.1111/j.1600-0609.2006.00693.x. [DOI] [PubMed] [Google Scholar]
  • 248.Nived P, Jorgensen CS, Settergren B. Vaccination status and immune response to 13-valent pneumococcal conjugate vaccine in asplenic individuals. Vaccine. 2015;33:1688–1694. doi: 10.1016/j.vaccine.2015.02.026. [DOI] [PubMed] [Google Scholar]
  • 249.Nordøy T, Husebekk A, Aaberge I, et al. Humoral immunity to viral and bacterial antigens in lymphoma patients 4–10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines. 2001. [DOI] [PubMed] [Google Scholar]
  • 250.Offidani M, Corvatta L, Olivieri A, et al. A Predictive Model of Varicella-Zoster Virus Infection after Autologous Peripheral Blood Progenitor Cell Transplantation. Clin Infect Dis. 2001;32:1414–1422. doi: 10.1086/320157. [DOI] [PubMed] [Google Scholar]
  • 251.Ojeda-Uribe M, Gilliot C, Jung G, et al. Administration of rituximab during the first trimester of pregnancy without consequences for the newborn. J Perinatol. 2006;26:252–255. doi: 10.1038/sj.jp.7211481. [DOI] [PubMed] [Google Scholar]
  • 252.Ojha RP, Jackson BE, Tota JE, et al. Younger age distribution of cervical cancer incidence among survivors of pediatric and young adult cancers. Gynecol Oncol. 2014;134:309–313. doi: 10.1016/j.ygyno.2014.05.011. [DOI] [PubMed] [Google Scholar]
  • 253.Ojha RP, Tota JE, Offutt-Powell TN, et al. Human papillomavirus-associated subsequent malignancies among long-term survivors of pediatric and young adult cancers. Plos One. 2013;8:e70349. doi: 10.1371/journal.pone.0070349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 254.Olarte L, Lin PL, Barson WJ, et al. Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era. Transpl Infect Dis. 2017 doi: 10.1111/tid.12630. [DOI] [PubMed] [Google Scholar]
  • 255.Oliveira LG, Sass N, Sato JL, et al. Pregnancy after renal transplantation—a five-yr single-center experience. Clin Transplant. 2007;21:301–304. doi: 10.1111/j.1399-0012.2006.00627.x. [DOI] [PubMed] [Google Scholar]
  • 256.Organtransplantation DS. Jahresbericht Organspende und Transplantation in Deutschland 2018. 2019. [Google Scholar]
  • 257.Orthopoulos GV, Theodoridou MC, Ladis VA, et al. The effect of 23-valent pneumococcal polysaccharide vaccine on immunological priming induced by 7-valent conjugate vaccine in asplenic subjects with beta-thalassemia. Vaccine. 2009;27:350–354. doi: 10.1016/j.vaccine.2008.10.070. [DOI] [PubMed] [Google Scholar]
  • 258.Pandit A, Leblebjian H, Hammond SP, et al. Safety of live-attenuated measles-mumps-rubella and herpes zoster vaccination in multiple myeloma patients on maintenance lenalidomide or bortezomib after autologous hematopoietic cell transplantation. Bone Marrow Transplant. 2018;53:942–945. doi: 10.1038/s41409-018-0112-x. [DOI] [PubMed] [Google Scholar]
  • 259.Papadatou I, Orthopoulos G, Theodoridou M, et al. Long-lasting hyporesponsivenss induced by the 23-valent pneumococcal polysaccharide vaccine (PPV23) in asplenic patients with beta-thalassemia major. Vaccine. 2015;33:3779–3783. doi: 10.1016/j.vaccine.2015.06.100. [DOI] [PubMed] [Google Scholar]
  • 260.Papadatou I, Piperi C, Alexandraki K, et al. Antigen-specific B-cell response to 13-valent pneumococcal conjugate vaccine in asplenic individuals with beta-thalassemia previously immunized with 23-valent pneumococcal polysaccharide vaccine. Clin Infect Dis. 2014;59:862–865. doi: 10.1093/cid/ciu409. [DOI] [PubMed] [Google Scholar]
  • 261.Park H, Youk J, Kim HR, et al. Infectious complications in multiple myeloma receiving autologous stem cell transplantation in the past 10 years. Int J Hematol. 2017;106:801–810. doi: 10.1007/s12185-017-2313-2. [DOI] [PubMed] [Google Scholar]
  • 262.Park ST, Song MJ, Park JS, et al. Incidence and clinicopathologic behavior of uterine cervical carcinoma in renal transplant recipients. World J Surg Oncol. 2011;9:72. doi: 10.1186/1477-7819-9-72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 263.Parkkali T, Kayhty H, Ruutu T, et al. A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT. Bone Marrow Transplant. 1996;18:961–967. [PubMed] [Google Scholar]
  • 264.Pasiarski M, Rolinski J, Grywalska E, et al. Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients—preliminary report. Plos One. 2014;9:e114966. doi: 10.1371/journal.pone.0114966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 265.Patel HS, Silver AR, Levine T, et al. Human papillomavirus infection and anal dysplasia in renal transplant recipients. Br J Surg. 2010;97:1716–1721. doi: 10.1002/bjs.7218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 266.Patel SR, Bate J, Borrow R, et al. Serotype-specific pneumococcal antibody concentrations in children treated for acute leukaemia. Arch Dis Child. 2012;97:46–48. doi: 10.1136/adc.2009.176271. [DOI] [PubMed] [Google Scholar]
  • 267.Patel SR, Ortin M, Cohen BJ, et al. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. Clin Infect Dis. 2007;44:625–634. doi: 10.1086/511641. [DOI] [PubMed] [Google Scholar]
  • 268.Paulides M, Stohr W, Laws HJ, et al. Antibody levels against tetanus and diphtheria after polychemotherapy for childhood sarcoma: a report from the Late Effects Surveillance System. Vaccine. 2011;29:1565–1568. doi: 10.1016/j.vaccine.2010.12.084. [DOI] [PubMed] [Google Scholar]
  • 269.Perez-Romero P, Aydillo TA, Perez-Ordonez A, et al. Reduced incidence of pneumonia in influenza-vaccinated solid organ transplant recipients with influenza disease. Clin Microbiol Infect. 2012;18:E533–E540. doi: 10.1111/1469-0691.12044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 270.Perez-Romero P, Bulnes-Ramos A, Torre-Cisneros J, et al. Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe. Clin Microbiol Infect. 2015;21(1040):e1011–1048. doi: 10.1016/j.cmi.2015.07.014. [DOI] [PubMed] [Google Scholar]
  • 271.Pergam SA, Forsberg CW, Boeckh MJ, et al. Herpes zoster incidence in a multicenter cohort of solid organ transplant recipients. Transpl Infect Dis. 2011;13:15–23. doi: 10.1111/j.1399-3062.2010.00547.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 272.Pergam SA, Limaye AP, Practice ASTIDCO. Varicella zoster virus in solid organ transplantation. Am J Transplant. 2013;13(4):138–146. doi: 10.1111/ajt.12107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 273.Perkins JL, Chen Y, Harris A, et al. Infections among long-term survivors of childhood and adolescent cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2014;120:2514–2521. doi: 10.1002/cncr.28763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 274.Petry KU, Scheffel D, Bode U, et al. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer. 1994;57:836–840. doi: 10.1002/ijc.2910570612. [DOI] [PubMed] [Google Scholar]
  • 275.Pham-Huy A, Sadarangani M, Huang V, et al. From mother to baby: antenatal exposure to monoclonal antibody biologics. Expert Rev Clin Immunol. 2019;15:221–229. doi: 10.1080/1744666X.2019.1561282. [DOI] [PubMed] [Google Scholar]
  • 276.Piñana JL, Montesinos P, Martino R, et al. Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients. Ann Hematol. 2014;93:299–307. doi: 10.1007/s00277-013-1872-4. [DOI] [PubMed] [Google Scholar]
  • 277.Piselli P, Busnach G, Fratino L, et al. De novo malignancies after organ transplantation: focus on viral infections. CMM. 2013;13:1217–1227. doi: 10.2174/15665240113139990041. [DOI] [PubMed] [Google Scholar]
  • 278.Pittet LF, Verolet CM, Mclin VA, et al. Multimodal safety assessment of measles-mumps-rubella vaccination after pediatric liver transplantation. Am J Transplant. 2019;19:844–854. doi: 10.1111/ajt.15101. [DOI] [PubMed] [Google Scholar]
  • 279.Posfay-Barbe KM, Pittet LF, Sottas C, et al. Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic. Am J Transplant. 2012;12:2974–2985. doi: 10.1111/j.1600-6143.2012.04273.x. [DOI] [PubMed] [Google Scholar]
  • 280.Prelog M, Schonlaub J, Jeller V, et al. Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients. Vaccine. 2013;31:2420–2426. doi: 10.1016/j.vaccine.2013.03.058. [DOI] [PubMed] [Google Scholar]
  • 281.Public Health Agency of Canada (2018) Blood Products, Human Immunoglobulin and Timing of Immunization: Canadian Immunization Guide. https://www.canada.ca/en/public-health/services/canadian-immunization-guide.html. Zugegriffen: 15. März 2020
  • 282.Public Health England . Immunisation against infectious disease. In: Ramsay M, editor. Meningococcal: the green book. London: Public Health England; 2013. p. 24. [Google Scholar]
  • 283.Public Health England . Immunisation against infectious disease. In: Ramsay M, editor. Rabies: the green book. London: Public Health England; 2012. pp. 1–14. [Google Scholar]
  • 284.Puyn L. Immunogenität und Verträglichkeit des hexavalenten Kombinationsimpfstoffs Infanrix hexaTM und des 7-valenten Pneumokokkenkonjugatimpfstoffs PrevenarTM bei Kindern nach allogener hämatopoetischer Stammzelltransplantation. Düsseldorf: Klinik für Kinder-Onkologie, -Hämatologie und Klinische Immunologie der Heinrich-Heine-Universität; 2016. p. 99. [Google Scholar]
  • 285.Ram S, Lewis LA, Rice PA. Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev. 2010;23:740–780. doi: 10.1128/CMR.00048-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 286.Ravandi F, O’brien S. Immune defects in patients with chronic lymphocytic leukemia. Cancer Immunol Immunother. 2006;55:197–209. doi: 10.1007/s00262-005-0015-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 287.Reed D, Brown G, Merrick R, et al. A Mumps Epidemic on St. George Island, Alaska. JAMA. 1967;199:967–971. doi: 10.1001/jama.199.13.113. [DOI] [PubMed] [Google Scholar]
  • 288.Reich G, Mapara MY, Reichardt P, et al. Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors. Bone Marrow Transplant. 2001;27:525–529. doi: 10.1038/sj.bmt.1702822. [DOI] [PubMed] [Google Scholar]
  • 289.Reynoso EE, Shepherd FA, Messner HA, et al. Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. J Clin Oncol. 1987;5:1098–1106. doi: 10.1200/JCO.1987.5.7.1098. [DOI] [PubMed] [Google Scholar]
  • 290.Rice TW, Rubinson L, Uyeki TM, et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med. 2012;40:1487–1498. doi: 10.1097/CCM.0b013e3182416f23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 291.Rieger CT, Liss B, Mellinghoff S, et al. Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) Ann Oncol : Off J Eur Soc Med Oncol. 2018;29:1354–1365. doi: 10.1093/annonc/mdy117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 292.Ritzwoller DP, Bridges CB, Shetterly S, et al. Effectiveness of the 2003–2004 Influenza Vaccine Among Children 6 Months to 8 Years of Age, With 1 vs 2 Doses. Pediatrics. 2005;116:153–159. doi: 10.1542/peds.2005-0049. [DOI] [PubMed] [Google Scholar]
  • 293.Rivera L, Pena LM, Stainier I, et al. Horizontal transmission of a human rotavirus vaccine strain—a randomized, placebo-controlled study in twins. Vaccine. 2011;29:9508–9513. doi: 10.1016/j.vaccine.2011.10.015. [DOI] [PubMed] [Google Scholar]
  • 294.Robin C, Beckerich F, Cordonnier C. Immunization in cancer patients: where we stand. Pharmacol Res. 2015;92:23–30. doi: 10.1016/j.phrs.2014.10.002. [DOI] [PubMed] [Google Scholar]
  • 295.Rogers JE, Cumpston A, Newton M, et al. Onset and complications of varicella zoster reactivation in the autologous hematopoietic cell transplant population. Transpl Infect Dis. 2011;13:480–484. doi: 10.1111/j.1399-3062.2011.00655.x. [DOI] [PubMed] [Google Scholar]
  • 296.Rogers ZR, Wang WC, Luo Z, et al. Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG Trial. Blood. 2011;117:2614–2617. doi: 10.1182/blood-2010-04-278747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 297.Rosado MM, Gesualdo F, Marcellini V, et al. Preserved antibody levels and loss of memory B cells against pneumococcus and tetanus after splenectomy: tailoring better vaccination strategies. Eur J Immunol. 2013;43:2659–2670. doi: 10.1002/eji.201343577. [DOI] [PubMed] [Google Scholar]
  • 298.Rosdahl A, Herzog C, Frosner G, et al. An extra priming dose of hepatitis A vaccine to adult patients with rheumatoid arthritis and drug induced immunosuppression—A prospective, open-label, multi-center study. Travel Med Infect Dis. 2018;21:43–50. doi: 10.1016/j.tmaid.2017.12.004. [DOI] [PubMed] [Google Scholar]
  • 299.Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58:309–318. doi: 10.1093/cid/cit816. [DOI] [PubMed] [Google Scholar]
  • 300.SAGE (2017) Proposed revision of the policy on rabies vaccines and rabies immunoglobulins. Prepared by the SAGE Working Group on Rabies vaccines and immunoglobulins and the World Health Organization (WHO) Secretariat
  • 301.Schiff GM. Titered Lots of Immune Globulin (Ig): Efficacy in the Prevention of Rubella. JAMA Pediatr. 1969;118:322–327. doi: 10.1001/archpedi.1969.02100040324029. [DOI] [PubMed] [Google Scholar]
  • 302.Schrauder A, Henke-Gendo C, Seidemann K, et al. Varicella vaccination in a child with acute lymphoblastic leukaemia. Lancet. 2007;369:1232. doi: 10.1016/S0140-6736(07)60567-4. [DOI] [PubMed] [Google Scholar]
  • 303.Schuchter LM, Wingard JR, Piantadosi S, et al. Herpes zoster infection after autologous bone marrow transplantation. Blood. 1989;74:1424–1427. [PubMed] [Google Scholar]
  • 304.Schwartz BS, Rosen J, Han PV, et al. Immunocompromised travelers: demographic characteristics, travel destinations, and Pretravel health care from the U.S. Global TravEpinet consortium. Am J Trop Med Hyg. 2015;93:1110–1116. doi: 10.4269/ajtmh.15-0185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 305.Schwartz PE, Sterioff S, Mucha P, et al. Postsplenectomy sepsis and mortality in adults. JAMA. 1982;248:2279–2283. [PubMed] [Google Scholar]
  • 306.Scully M, Starke R, Lee R, et al. Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura. Blood Coagulation Fibrinolysis : Int J Haemostasis Thromb. 2006;17:459–463. doi: 10.1097/01.mbc.0000240918.65306.20. [DOI] [PubMed] [Google Scholar]
  • 307.Serio B, Pezzullo L, Giudice V, et al. OPSI threat in hematological patients. Transl Med UniSa. 2013;6:2–10. [PMC free article] [PubMed] [Google Scholar]
  • 308.Serrano B, Bayas JM, Bruni L, et al. Solid organ transplantation and response to vaccination. Vaccine. 2007;25:7331–7338. doi: 10.1016/j.vaccine.2007.08.031. [DOI] [PubMed] [Google Scholar]
  • 309.Sharma-Chawla N, Sender V, Kershaw O, et al. Influenza A Virus Infection Predisposes Hosts to Secondary Infection with Different Streptococcus pneumoniae Serotypes with Similar Outcome but Serotype-Specific Manifestation. Infect Immun. 2016;84:3445–3457. doi: 10.1128/IAI.00422-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 310.Shatz DV. Vaccination considerations in the asplenic patient. Expert Rev Vaccines. 2005;4:27–34. doi: 10.1586/14760584.4.1.27. [DOI] [PubMed] [Google Scholar]
  • 311.Shinjoh M, Hoshino K, Takahashi T, et al. Updated data on effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation. Vaccine. 2015;33:701–707. doi: 10.1016/j.vaccine.2014.11.052. [DOI] [PubMed] [Google Scholar]
  • 312.Shinjoh M, Miyairi I, Hoshino K, et al. Effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation. Vaccine. 2008;26:6859–6863. doi: 10.1016/j.vaccine.2008.09.076. [DOI] [PubMed] [Google Scholar]
  • 313.Siber Gr WB, Halsey NRR, Almeido-Hill J, Sc G, Thompson C, Santosham M. Interference of immune globulin with measles and rubella immunization. J Pediatr. 1993;122:204–211. doi: 10.1016/s0022-3476(06)80114-9. [DOI] [PubMed] [Google Scholar]
  • 314.Sicre De Fontbrune F, Arnaud C, Cheminant M, et al. Immunogenicity and Safety of Yellow Fever Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients After Withdrawal of Immunosuppressive Therapy. J INFECT DIS. 2018;217:494–497. doi: 10.1093/infdis/jix564. [DOI] [PubMed] [Google Scholar]
  • 315.Sinisalo M, Aittoniemi J, Oivanen P, et al. Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia. Br J Haematol. 2001;114:107–110. doi: 10.1046/j.1365-2141.2001.02882.x. [DOI] [PubMed] [Google Scholar]
  • 316.Sinwar PD. Overwhelming post splenectomy infection syndrome—review study. Int J Surg. 2014;12:1314–1316. doi: 10.1016/j.ijsu.2014.11.005. [DOI] [PubMed] [Google Scholar]
  • 317.Small TN, Avigan D, Dupont B, et al. Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow. Transplantation. 1997;3:65–75. [PubMed] [Google Scholar]
  • 318.Smedegaard LM, Poulsen A, Kristensen IA, et al. Varicella Vaccination of Children With Leukemia Without Interruption of Maintenance Therapy: A Danish Experience. Pediatr Infect Dis J. 2016;35:e348–e352. doi: 10.1097/INF.0000000000001279. [DOI] [PubMed] [Google Scholar]
  • 319.Smets F, Bourgois A, Vermylen C, et al. Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine. Vaccine. 2007;25:5278–5282. doi: 10.1016/j.vaccine.2007.05.014. [DOI] [PubMed] [Google Scholar]
  • 320.Smith LH, Dalrymple JL, Leiserowitz GS, et al. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol. 2001;184:1504–1512. doi: 10.1067/mob.2001.114867. [DOI] [PubMed] [Google Scholar]
  • 321.Smith S, Schiffman G, Karayalcin G, et al. Immunodeficiency in long-term survivors of acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munster therapy. J Pediatr. 1995;127:68–75. doi: 10.1016/s0022-3476(95)70259-8. [DOI] [PubMed] [Google Scholar]
  • 322.Spoulou V, Tzanakaki G, Lekka S, et al. Natural and vaccine-induced immunity to Neisseria meningitidis serogroup C in asplenic patients with beta-thalassemia. Vaccine. 2011;29:4435–4438. doi: 10.1016/j.vaccine.2011.03.080. [DOI] [PubMed] [Google Scholar]
  • 323.Stadtmauer EA, Sullivan KM, Marty FM, et al. A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients. Blood. 2014;124:2921–2929. doi: 10.1182/blood-2014-04-573048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 324.Staehelin C, Hirzel C, Hauser C, et al. Vaccinations for immunocompromised hosts—focussing on patients after a hematological stem cell or organ transplantation, with HIV or with functional or anatomical asplenia]. Therapeutische Umschau. Ther Umsch. 2016;73:281–289. doi: 10.1024/0040-5930/a000793. [DOI] [PubMed] [Google Scholar]
  • 325.Stammzelltransplantationen DRF. Jahresbericht 2018 Deutsches Register für Stammzelltransplantationen. 2018. [Google Scholar]
  • 326.Ständige Impfkommission Aktualisierung der Meningokokken-Impfempfehlung: Anwendung des Meningokokken-B-Impfstoffs bei Personen mit erhöhtem Risiko für Meningokokken-Erkrankungen. Epidemiol Bull. 2015;37:393–410. [Google Scholar]
  • 327.Ständige Impfkommission Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Epidemiol Bull. 2019;34:313–364. [Google Scholar]
  • 328.Ständige Impfkommission Mitteilung der Ständigen Impfkommission (STIKO) am RKI – Empfehlung und wissenschaftliche Begründung der Empfehlung zur Rotavirus-Standardimpfung von Säuglingen. Epidemiol Bull. 2013;35:349–361. [Google Scholar]
  • 329.Ständige Impfkommission Mitteilung der Ständigen Impfkommission am Robert Koch-Institut (RKI) – Wissenschaftliche Begründung für die Aktualisierung der Pneumokokken-Impfempfehlung für Senioren. Epid Bull. 2016;36:351–383. [Google Scholar]
  • 330.Ständige Impfkommission Stellungnahme der STIKO: Fachliche Anwendungshinweise zur Masern-Postexpositionsprophylaxe bei Risikopersonen. Epid Bull. 2017 doi: 10.17886/EpiBull-2017-002.1. [DOI] [Google Scholar]
  • 331.Ständige Impfkommission Wissenschaftliche Begründung für die Aktualisierung der Empfehlungen zur Indikationsimpfung gegen Pneumokokken für Risikogruppen. Epidemiol Bull. 2016;37:385–406. [Google Scholar]
  • 332.Ständige Impfkommission Wissenschaftliche Begründung für die Änderung der Empfehlung zur Impfung gegen Hepatitis B. Epid Bull. 2013;36/37:371–381. [Google Scholar]
  • 333.Ständige Impfkommission Wissenschaftliche Begründung für die geänderte Empfehlung zur Anwendung von Influenza-Impfstoffen bei Kindern und Jugendlichen im Alter von 2–17 Jahren. Epid Bull. 2017;35:384–385. [Google Scholar]
  • 334.Ständige Impfkommission Wissenschaftliche Begründung zur Empfehlung einer Impfung mit dem Herpes zoster-subunit-Totimpfstoff. Epidemiol Bull. 2018;50:541–567. [Google Scholar]
  • 335.Stanford E, Print F, Falconer M, et al. Immune response to pneumococcal conjugate vaccination in asplenic individuals. Hum Vaccin. 2009;5:85–91. doi: 10.4161/hv.5.2.6557. [DOI] [PubMed] [Google Scholar]
  • 336.Stark K, Gunther M, Neuhaus R, et al. Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. J INFECT DIS. 1999;180:2014–2017. doi: 10.1086/315125. [DOI] [PubMed] [Google Scholar]
  • 337.Steininger PA, Bobinger T, Dietrich W, et al. Two Cases of Severe Tick-Borne Encephalitis in Rituximab-Treated Patients in Germany: Implications for Diagnosis and Prevention. Open Forum Infect Dis. 2017;4:ofx204. doi: 10.1093/ofid/ofx204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 338.Sternfeld T, Spori-Byrtus V, Riediger C, et al. Acute measles infection triggering an episode of liver transplant rejection. Int J Infect Dis. 2010;14:e528–530. doi: 10.1016/j.ijid.2009.06.013. [DOI] [PubMed] [Google Scholar]
  • 339.Stoehr GA, Rose MA, Eber SW, et al. Immunogenicity of sequential pneumococcal vaccination in subjects splenectomised for hereditary spherocytosis. Br J Haematol. 2006;132:788–790. doi: 10.1111/j.1365-2141.2005.05918.x. [DOI] [PubMed] [Google Scholar]
  • 340.Storek J, Witherspoon RP, Storb R. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant. 1995;16:413–425. [PubMed] [Google Scholar]
  • 341.Struijk GH, Minnee RC, Koch SD, et al. Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses. Kidney Int. 2010;78:934–940. doi: 10.1038/ki.2010.269. [DOI] [PubMed] [Google Scholar]
  • 342.Su SH, Martel-Laferriere V, Labbe AC, et al. High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2011;17:1012–1017. doi: 10.1016/j.bbmt.2010.10.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 343.Sun C, Gao J, Couzens L, et al. Seasonal Influenza Vaccination in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib. JAMA Oncol. 2016;2:1656–1657. doi: 10.1001/jamaoncol.2016.2437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 344.Tadmor T, Welslau M, Hus I. A review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemia. Expert Rev Hematol. 2018;11:57–70. doi: 10.1080/17474086.2018.1407645. [DOI] [PubMed] [Google Scholar]
  • 345.Takata T, Suzumiya J, Ishikawa T, et al. Attenuated antibody reaction for the primary antigen but not for the recall antigen of influenza vaccination in patients with non-Hodgkin B-cell lymphoma after the administration of rituximab-CHOP. J Clin Exp Hematop. 2009;49:9–13. doi: 10.3960/jslrt.49.9. [DOI] [PubMed] [Google Scholar]
  • 346.Tangye SG, Good KL. Human IgM+CD27+ B cells: memory B cells or “memory” B cells? J Immunol. 2007;179:13–19. doi: 10.4049/jimmunol.179.1.13. [DOI] [PubMed] [Google Scholar]
  • 347.Theilacker C, Ludewig K, Serr A, et al. Overwhelming Postsplenectomy Infection: A Prospective Multicenter Cohort Study. Clin Infect Dis. 2016;62:871–878. doi: 10.1093/cid/civ1195. [DOI] [PubMed] [Google Scholar]
  • 348.Thomsen RW, Schoonen WM, Farkas DK, et al. Risk for hospital contact with infection in patients with splenectomy: a population-based cohort study. Ann Intern Med. 2009;151:546–555. doi: 10.7326/0003-4819-151-8-200910200-00008. [DOI] [PubMed] [Google Scholar]
  • 349.Thomson KJ, Hart DP, Banerjee L, et al. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation. Bone Marrow Transplant. 2005;35:1065–1069. doi: 10.1038/sj.bmt.1704959. [DOI] [PubMed] [Google Scholar]
  • 350.Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009;15:1143–1238. doi: 10.1016/j.bbmt.2009.06.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 351.Tran L, Hebert D, Dipchand A, et al. Invasive pneumococcal disease in pediatric organ transplant recipients: a high-risk population. Pediatr Transplantation. 2005;9:183–186. doi: 10.1111/j.1399-3046.2005.00275.x. [DOI] [PubMed] [Google Scholar]
  • 352.Trubiano JA, Johnson D, Sohail A, Torresi J. Travel vaccination recommendations and endemic infection risks in solid organ transplantation recipients. J Travel Med. 2016 doi: 10.1093/jtm/taw058. [DOI] [PubMed] [Google Scholar]
  • 353.Tsolia M, Gershon AA, Steinberg SP, et al. Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group. J Pediatr. 1990;116:184–189. doi: 10.1016/s0022-3476(05)82872-0. [DOI] [PubMed] [Google Scholar]
  • 354.Udink Ten Cate FE, Ten Hove CH, Nix WM, et al. Transient neonatal myelosuppression after fetal exposure to maternal chemotherapy. Case report and review of the literature. Neonatology. 2009;95:80–85. doi: 10.1159/000151759. [DOI] [PubMed] [Google Scholar]
  • 355.Ullmann AJ, Schmidt-Hieber M, Bertz H, et al. Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016. Ann. Hematol. 2016;95:1435–1455. doi: 10.1007/s00277-016-2711-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 356.Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical practice guidelines by the infectious diseases society of america: 2018 update on diagnosis, treatment, Chemoprophylaxis, and institutional outbreak management of seasonal Influenzaa. Clin Infect Dis. 2018;68:e1–e47. doi: 10.1093/cid/ciy866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 357.Van De Wetering Vossen Jansen MDMTMH, et al. Varicella vaccination in pediatric oncology patients without interruption of chemotherapy. J Clin Virol. 2016;75:47–52. doi: 10.1016/j.jcv.2016.01.004. [DOI] [PubMed] [Google Scholar]
  • 358.Van Der Kolk LE, Baars JW, Prins MH, et al. Rituximab treatment results in impaired secondary humoral immune responsiveness. Blood. 2002;100:2257–2259. [PubMed] [Google Scholar]
  • 359.Van Der Velden AM, Claessen AM, Van Velzen-Blad H, et al. Development of functional Haemophilus influenzae type b antibodies after vaccination. Haematologica. 2005;90:1582–1584. [PubMed] [Google Scholar]
  • 360.Van Der Velden AM, Claessen AM, Van Velzen-Blad H, et al. Vaccination responses and lymphocyte subsets after autologous stem cell transplantation. Vaccine. 2007;25:8512–8517. doi: 10.1016/j.vaccine.2007.10.008. [DOI] [PubMed] [Google Scholar]
  • 361.Van Tilburg CM, Sanders EA, Rovers MM, et al. Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: a systematic review. Leukemia. 2006;20:1717–1722. doi: 10.1038/sj.leu.2404326. [DOI] [PubMed] [Google Scholar]
  • 362.Vance E, George S, Guinan EC, et al. Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation. Bone Marrow Transplant. 1998;22:735–741. doi: 10.1038/sj.bmt.1701424. [DOI] [PubMed] [Google Scholar]
  • 363.Vardhana S, Cicero K, Velez MJ, et al. Strategies for Recognizing and Managing Immune-Mediated Adverse Events in the Treatment of Hodgkin Lymphoma with Checkpoint Inhibitors. The Oncol. 2019;24:86–95. doi: 10.1634/theoncologist.2018-0045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 364.Vernacchio L, Neufeld EJ, Macdonald K, et al. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease. J Pediatr. 1998;133:275–278. doi: 10.1016/s0022-3476(98)70235-5. [DOI] [PubMed] [Google Scholar]
  • 365.Vesikari T, Karvonen A, Korhonen T, et al. A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine. Pediatr Infect Dis J. 2006;25:590–595. doi: 10.1097/01.inf.0000220229.51531.47. [DOI] [PubMed] [Google Scholar]
  • 366.Vincent P. The immunocompromised traveller. South African J Epidemiol Infect. 2008;23:22–26. [Google Scholar]
  • 367.Vink P, Torrell RJM, Sanchez Fructuoso A, et al. Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial. Clin Infect Dis. 2020;70:181–190. doi: 10.1093/cid/ciz177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 368.Vinograd I, Eliakim-Raz N, Farbman L, et al. Clinical effectiveness of seasonal influenza vaccine among adult cancer patients. Cancer. 2013;119:4028–4035. doi: 10.1002/cncr.28351. [DOI] [PubMed] [Google Scholar]
  • 369.Vu HT, Yoshida LM, Suzuki M, et al. Association between nasopharyngeal load of Streptococcus pneumoniae, viral coinfection, and radiologically confirmed pneumonia in Vietnamese children. Pediatr Infect Dis J. 2011;30:11–18. doi: 10.1097/INF.0b013e3181f111a2. [DOI] [PubMed] [Google Scholar]
  • 370.Waghorn DJ. Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. J Clin Pathol. 2001;54:214–218. doi: 10.1136/jcp.54.3.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 371.Waghorn DJ, Mayon-White RT. A study of 42 episodes of overwhelming post-splenectomy infection: is current guidance for asplenic individuals being followed? J Infect. 1997;35:289–294. doi: 10.1016/s0163-4453(97)93232-1. [DOI] [PubMed] [Google Scholar]
  • 372.Wagner N, Assmus F, Arendt G, et al. Impfen bei Immundefizienz: Anwendungshinweise zu den von der Ständigen Impfkommision empfohlenen Impfungen. (IV) Impfen bei Autoimmunkrankheiten, bei anderen chronisch-entzündlichen Erkrankungen und unter immunmodulatorischer Therapie. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019;62:494–515. doi: 10.1007/s00103-019-02905-1. [DOI] [PubMed] [Google Scholar]
  • 373.Wang SH, Loh PY, Lin TL, et al. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft. Liver Transpl. 2017;23:1266–1272. doi: 10.1002/lt.24814. [DOI] [PubMed] [Google Scholar]
  • 374.Weil BR, Madenci AL, Liu Q, et al. Late Infection-Related Mortality in Asplenic Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2018;36:1571–1578. doi: 10.1200/JCO.2017.76.1643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 375.Weitberg AB, Weitzman SA, Watkins E, et al. Immunogenicity of hepatitis B vaccine in oncology patients receiving chemotherapy. J Clin Oncol. 1985;3:718–722. doi: 10.1200/JCO.1985.3.5.718. [DOI] [PubMed] [Google Scholar]
  • 376.Weller S, Braun MC, Tan BK, et al. Human blood IgM “memory” B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood. 2004;104:3647–3654. doi: 10.1182/blood-2004-01-0346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 377.Wiedermann U, Sitte HH, Burgmann H, et al. Guidelines for vaccination of immunocompromised individuals. Wien Klin Wochenschr. 2016;128(4):337–376. doi: 10.1007/s00508-016-1033-6. [DOI] [PubMed] [Google Scholar]
  • 378.Wieten RW, Goorhuis A, Jonker EFF, et al. 17D yellow fever vaccine elicits comparable long-term immune responses in healthy individuals and immune-compromised patients. J Infect. 2016;72:713–722. doi: 10.1016/j.jinf.2016.02.017. [DOI] [PubMed] [Google Scholar]
  • 379.Wijn DH, Groeneveld GH, Vollaard AM, et al. Influenza vaccination in patients with lung cancer receiving anti-programmed death receptor 1 immunotherapy does not induce immune-related adverse events. Eur J Cancer. 2018;104:182–187. doi: 10.1016/j.ejca.2018.09.012. [DOI] [PubMed] [Google Scholar]
  • 380.Wimperis JZ, Brenner MK, Prentice HG, et al. Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet. 1986;1:339–343. doi: 10.1016/s0140-6736(86)92315-9. [DOI] [PubMed] [Google Scholar]
  • 381.Wong A, Marrie TJ, Garg S, et al. Increased risk of invasive pneumococcal disease in haematological and solid-organ malignancies. Epidemiol Infect. 2010;138:1804–1810. doi: 10.1017/S0950268810000919. [DOI] [PubMed] [Google Scholar]
  • 382.World health Organization (2019) Yellow Fever. https://www.who.int/news-room/fact-sheets/detail/yellow-fever. Zugegriffen: 4. April 2020
  • 383.World Health Organization WHO Expert Consultation on Rabies. World Health Organ Tech Rep Ser. 2018;3:1–195. [Google Scholar]
  • 384.Wumkes ML, Van Der Velden AM, Los M, et al. Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumours. Vaccine. 2013;31:6177–6184. doi: 10.1016/j.vaccine.2013.10.053. [DOI] [PubMed] [Google Scholar]
  • 385.Wyplosz B, Burdet C, Francois H, et al. Persistence of yellow fever vaccine-induced antibodies after solid organ transplantation. Am J Transplant. 2013;13:2458–2461. doi: 10.1111/ajt.12338. [DOI] [PubMed] [Google Scholar]
  • 386.Yax JA, Farnon EC, Engleberg CN. Successful immunization of an allogeneic bone marrow transplant recipient with live, attenuated yellow Fever vaccine. J Travel Med. 2009;16:365–367. doi: 10.1111/j.1708-8305.2009.00336.x. [DOI] [PubMed] [Google Scholar]
  • 387.Young MK, Cripps AW, Nimmo GR, van Driel ML. Post-exposure passive immunisation for preventing rubella and congenital rubella syndrome. Cochrane Database Syst Rev. 2015 doi: 10.1002/14651858.CD010586.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 388.Youssef S, Rodriguez G, Rolston KV, et al. Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989–2005. Medicine. 2007;86:69–77. doi: 10.1097/md.0b013e31803eb176. [DOI] [PubMed] [Google Scholar]
  • 389.Zheng S, Easterling TR, Hays K, et al. Tacrolimus placental transfer at delivery and neonatal exposure through breast milk. Br J Clin Pharmacol. 2013;76:988–996. doi: 10.1111/bcp.12122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 390.Zignol M, Peracchi M, Tridello G, et al. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Cancer. 2004;101:635–641. doi: 10.1002/cncr.20384. [DOI] [PubMed] [Google Scholar]

Articles from Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz are provided here courtesy of Nature Publishing Group

RESOURCES